Industry & Company News

Ken VanLuvanee, President & CEO   It was a wonderful 2023 for the team at Facet Life Sciences.  We had some fun, welcomed several new team members into the Facet family, joined hands with several new clients, and advanced s...

Congratulations to Dr. Jason Mercer ! Dr. Jason Mercer has been chosen to serve as a committee member on the Food and Drug Law Institute’s (FDLI) Medical Products committee this year.  As part of the committee, Dr. Mercer...

Partner News Facet is delighted to announce a partnership with Veramed.  Veramed is a pioneering CRO redefining intelligent healthcare decision-making.  As trusted industry specialists, Veramed’s global team provides next-level...

FDA ROUNDUP: FDA Issues New User Fees for 2023-2024 – Costs Are Going Up! If you are submitting an NDA or BLA application that includes clinical data in 2023 or 2024, you will pay $3.24M, and a whopping $4.04M, respectively!  P...

RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTSFACET HELPS GOVERNMENT INVESTIGATE DEA DRUG OF CONCERN: Facet champions IND preparation and submission to study PK and safety of widely available supplement.  A large ex-US CRO and ...

Congratulations to Michelle Byrne! Michelle has just been awarded her RAC. We’re so proud of her achievement. Regulatory Affairs Certification (RAC), is the only post-academic professional credential for regulatory professional...

Come explore new paths with us at the 2023 AusBiotech Conference in Brisbane, Australia. November 1-3 Find us in Booth #21

Come explore with us at the 2023 SNMMI Therapeutics Conference. September 21-23 Find us in Booth #16 Regulatory guidance and support designed specifically for radiopharm More radiopharm open INDs and approved NDAs than anyone i...

RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTSINDUSTRY FIRST FOR MEDICAL DEVICES:   Facet is the first organization to work with the FDA and a medical device Sponsor to prepare and submit a combination product 510(k) using the ...

Facet Life Sciences, a leading provider of regulatory strategy and consulting services, has been recognized as one of the top ten regulatory companies for 2023 by Life Sciences Review. We work with clients to understan...